Debby Damm

Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor

Philippe Bonniaud, Peter J. Margetts, Martin Kolb et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 252 citations

Fibrosis, Inflammatory Lung Disease, Lung Inflammation +15

IFN-<i>beta</i> 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

Reinhard Kirnbauer, A Köck, Thomas Schwarz et al. · The Journal of Immunology · 1989 · 203 citations

Transforming Growth Factor-β Receptor Type 1 (TGFβRI) Kinase Activity but Not p38 Activation Is Required for TGFβRI-Induced Myofibroblast Differentiation and Profibrotic Gene Expression

Ann M. Kapoun, N. J. Gaspar, Ying Wang et al. · Molecular Pharmacology · 2006 · 75 citations

Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation

Aaron Nguyen, Elizabeth G. Stebbins, Margaret Henson et al. · Experimental Cell Research · 2006 · 64 citations

Hematological Malignancy, Bone Morphogenic Protein, Malignant Blood Disorder +7

B-Type Natriuretic Peptide Inhibited Angiotensin II-Stimulated Cholesterol Biosynthesis, Cholesterol Transfer, and Steroidogenesis in Primary Human Adrenocortical Cells

Faquan Liang, Ann M. Kapoun, Andrew Lam et al. · Endocrinology · 2007 · 36 citations